NeuroOne Medical Technologies Corporation (NMTC)

NMTC Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	12.1	3.45	3.41	2.12	0.24
Revenue Growth (YoY)	250.35%	1.33%	60.73%	772.60%	-87.39%
Cost of Revenue	8.94	7.44	8.44	5.17	4.2
Gross Profit	3.16	-3.99	-5.03	-3.05	-3.96
Selling, General & Admin	7.38	7.9	6.93	6.98	6.26
Operating Expenses	7.38	7.9	6.93	6.98	6.26
Operating Income	-4.23	-11.89	-11.96	-10.03	-10.22
Interest Expense	-0.2	-0.1	-	-	-0
Interest & Investment Income	-	-	0.2	-	-
Other Non Operating Income (Expenses)	0.82	-0.33	-0.07	0.03	-0.01
EBT Excluding Unusual Items	-3.61	-12.32	-11.83	-10	-10.23
Gain (Loss) on Sale of Assets	-	-	-0.03	-	-
Legal Settlements	-	-	-	-	0.2
Other Unusual Items	-	-	-	-	0.08
Pretax Income	-3.61	-12.32	-11.86	-10	-9.95
Net Income	-3.61	-12.32	-11.86	-10	-9.95
Net Income to Common	-3.61	-12.32	-11.86	-10	-9.95
Shares Outstanding (Basic)	40	27	18	16	11
Shares Outstanding (Diluted)	40	27	18	16	11
Shares Change (YoY)	50.03%	47.69%	13.27%	49.56%	97.52%
EPS (Basic)	-0.09	-0.46	-0.65	-0.63	-0.93
EPS (Diluted)	-0.09	-0.46	-0.65	-0.63	-0.93
Free Cash Flow	-2.92	-11.13	-13.27	-7.79	-8.67
Free Cash Flow Per Share	-0.07	-0.42	-0.73	-0.49	-0.81
Gross Margin	26.11%	-115.42%	-147.58%	-143.93%	-
Operating Margin	-34.94%	-344.26%	-350.84%	-473.14%	-4205.75%
Profit Margin	-29.80%	-356.74%	-348.03%	-471.67%	-4094.60%
Free Cash Flow Margin	-24.13%	-322.39%	-389.45%	-367.67%	-3568.48%
EBITDA	-3.96	-11.64	-11.76	-9.91	-10.14
EBITDA Margin	-32.77%	-	-	-	-
D&A For EBITDA	0.26	0.25	0.2	0.12	0.08
EBIT	-4.23	-11.89	-11.96	-10.03	-10.22
EBIT Margin	-34.94%	-	-	-	-
Advertising Expenses	0.17	0.11	0.17	0.27	0.34

Updated Dec 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q